It is a chemicals private limited company based in Bagalkot, Karnataka, India, established in 2012.
2012 | Bagalkot, Karnataka, India | ActiveElinx Pharmaceuticals India Private Limited, a active private limited company, was established on 29 October 2012 in Bagalkot, Karnataka, India. Engaging in medicinal chemical & botanical products within the trade sector, it holds CIN: U24232KA2012PTC066497. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Vijayakumar Kadappa Hosatti (Director), Kalyanappa Revanasiddappa Masali (Director), Manjunath Adiveppa Konnur (Director). Past directors included Shrishail Somanna Hatti, Chidanand Parayya Hiremath, Manjunath Adiveppa Konnur. It holds ₹1.19 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Sy No : 542, Plot N: 62, Basavanagar, Mudhol,, Bagalkot, Karnataka, 587313.
U24232KA2012PTC066497
066497
29 October 2012
₹0.10 M
₹0.10 M
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Elinx Pharmaceuticals India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vijayakumar Kadappa Hosatti | Director | 29 Oct 2012 | Current |
| Kalyanappa Revanasiddappa Masali | Director | 29 Oct 2012 | Current |
| Manjunath Adiveppa Konnur | Director | 28 May 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 26 May 2015 | Past |
| Pramod Abcsdd | Director | 26 May 2015 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2022 | Past |
| Pramod Abcsdd | Director | 02 Mar 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Elinx Pharmaceuticals India Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 152.04% increase. The company also saw a substantial improvement in profitability, with a 334.43% increase in profit. The company's net worth Soared by an impressive increase of 20.27%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2017, Elinx Pharmaceuticals India had a promoter holding of 78.00% and a public holding of 22.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹1,185,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Feb 2022 | Indian Bank | ₹0.24 M | Open |
| 16 Jul 2021 | Indian Bank | ₹0.95 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Elinx Pharmaceuticals India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Elinx Pharmaceuticals India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Elinx Pharmaceuticals India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Elinx Pharmaceuticals India Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Elinx Pharmaceuticals India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore. was recorded as a recent event.
Progress on Manjunath Adiveppa Konnur was appointed as a Director was appointed as a Director on 28 May 2022 & has been associated with this company since 3 years 5 months . was documented.
Progress on A charge with Indian Bank amounted to Rs. 0.24 M with Charge ID 100578074 was registered on 19 Feb 2022. was documented.
A charge with Indian Bank amounted to Rs. 0.95 M with Charge ID 100462197 was registered on 16 Jul 2021. was recorded as a recent event.
Progress on Vijayakumar Kadappa Hosatti was appointed as a Director was appointed as a Director on 29 Oct 2012 & has been associated with this company since 13 years 26 days . was documented.
The CIN of Elinx Pharmaceuticals India Private Limited is U24232KA2012PTC066497.
Elinx Pharmaceuticals India Private Limited is headquartered at Sy No : 542, Plot N: 62, Basavanagar, Mudhol,, Bagalkot, Karnataka, 587313.
Elinx Pharmaceuticals India Private Limited was incorporated on 29 October 2012.
The current directors of Elinx Pharmaceuticals India Private Limited are
The primary industry of Elinx Pharmaceuticals India Private Limited is Trade.
Elinx Pharmaceuticals India Private Limited is unlisted.
The authorized capital of Elinx Pharmaceuticals India Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Elinx Pharmaceuticals India Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX